| __timestamp | Takeda Pharmaceutical Company Limited | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 382096000000 | 396000000 |
| Thursday, January 1, 2015 | 345927000000 | 364000000 |
| Friday, January 1, 2016 | 312303000000 | 376000000 |
| Sunday, January 1, 2017 | 325441000000 | 382000000 |
| Monday, January 1, 2018 | 368298000000 | 432000000 |
| Tuesday, January 1, 2019 | 492381000000 | 457000000 |
| Wednesday, January 1, 2020 | 455833000000 | 463000000 |
| Friday, January 1, 2021 | 526087000000 | 508000000 |
| Saturday, January 1, 2022 | 633325000000 | 539000000 |
| Sunday, January 1, 2023 | 729924000000 | 614000000 |
| Monday, January 1, 2024 | 729924000000 | 686000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, research and development (R&D) are the lifeblood of innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Zoetis Inc. have demonstrated contrasting R&D investment strategies. Takeda, a global leader, has consistently increased its R&D budget, peaking at a staggering 730 billion yen in 2023, reflecting a 91% growth since 2014. This commitment underscores Takeda's dedication to pioneering new treatments and maintaining its competitive edge.
Conversely, Zoetis Inc., a key player in animal health, has shown a more modest R&D growth. From 2014 to 2023, Zoetis's R&D expenses rose by approximately 55%, reaching 614 million dollars. This strategic allocation highlights Zoetis's focus on targeted innovations within its niche market. Notably, data for 2024 is incomplete, suggesting potential shifts in these trends. As these companies forge ahead, their R&D investments will continue to shape the future of healthcare.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Zoetis Inc.
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Exelixis, Inc.
Research and Development Investment: Zoetis Inc. vs Verona Pharma plc
Research and Development: Comparing Key Metrics for Zoetis Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and BeiGene, Ltd.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and MorphoSys AG
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Dynavax Technologies Corporation
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and MiMedx Group, Inc.